Treating infertility caused by thin endometrium through the administration of Platelet-rich plasma

Treating refractory thin endometrium through a novel way of activation and administration of Platelet-rich plasma in sexually active Syrian Women: An interventional prospective cohort clinical study - TRTETANWOAAAOPRPISASWAIPCCS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000050227

Enrollment

Registered

2023-02-09

Start date

2022-02-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory thin endometrium

Interventions

A number of PRP injections in the cervix in the location of 6 and 12 o&#39

clock and in the quadriceps femoris and the contralateral triceps brachii simultaneously, and PRP infusion in the uterine cavity, the number of PRP rounds differ depending on the patient.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients aged 22 to 47 who suffer from infertility and diagnosed with refractory thin endometrium with: maximal endometrial thickness of <6 mm. low AMH levels (AMH < 1.5 ng/ml) (or normal/high AMH after excluding other possible causes of infertility). irregular periods. idiopathic infertility after trying conventional treatment methods. patients with secondary infertility after treating the underlined cause.

Exclusion criteria

Exclusion criteria: Exclusion criteria were effective hormonal therapy, effective in-vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).

Design outcomes

Primary

Measure	Time frame
Improving endometrial thickness and improving fertility	—

Countries

Asia(except Japan)

Contacts

Public ContactM SUBHI MURAD

Damascus University Faculty of medicine

subhimu13shiro@gmail.com00963995666124

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026